COLLEGIUM PHARMACEUTICAL INC (COLL) Stock Fundamental Analysis
NASDAQ:COLL - Nasdaq - US19459J1043 - Common Stock - Currency: USD
Overall COLL gets a fundamental rating of 6 out of 10. We evaluated COLL against 198 industry peers in the Pharmaceuticals industry. While COLL has a great profitability rating, there are some minor concerns on its financial health. COLL is valued quite cheap, while showing a decent growth score. This is a good combination! This makes COLL very considerable for value investing!
1. Profitability
1.1 Basic Checks
In the past year COLL was profitable.
COLL had a positive operating cash flow in the past year.
COLL had positive earnings in 4 of the past 5 years.
In the past 5 years COLL always reported a positive cash flow from operatings.
1.2 Ratios
COLL has a better Return On Assets (2.69%) than 84.85% of its industry peers.
Looking at the Return On Equity, with a value of 18.72%, COLL belongs to the top of the industry, outperforming 90.91% of the companies in the same industry.
COLL has a Return On Invested Capital of 8.30%. This is amongst the best in the industry. COLL outperforms 85.86% of its industry peers.
The Average Return On Invested Capital over the past 3 years for COLL is significantly below the industry average of 42.34%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROIC | 8.3% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
1.3 Margins
With an excellent Profit Margin value of 6.61%, COLL belongs to the best of the industry, outperforming 84.85% of the companies in the same industry.
COLL's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 21.39%, COLL belongs to the top of the industry, outperforming 87.37% of the companies in the same industry.
In the last couple of years the Operating Margin of COLL has grown nicely.
Looking at the Gross Margin, with a value of 57.69%, COLL is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
COLL's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% |
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), COLL is creating some value.
Compared to 1 year ago, COLL has less shares outstanding
The number of shares outstanding for COLL has been reduced compared to 5 years ago.
Compared to 1 year ago, COLL has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.98, we must say that COLL is in the distress zone and has some risk of bankruptcy.
COLL's Altman-Z score of 0.98 is fine compared to the rest of the industry. COLL outperforms 62.63% of its industry peers.
The Debt to FCF ratio of COLL is 4.26, which is a neutral value as it means it would take COLL, 4.26 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 4.26, COLL belongs to the best of the industry, outperforming 85.35% of the companies in the same industry.
A Debt/Equity ratio of 3.30 is on the high side and indicates that COLL has dependencies on debt financing.
The Debt to Equity ratio of COLL (3.30) is worse than 80.30% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Altman-Z | 0.98 |
ROIC/WACC0.87
WACC9.58%
2.3 Liquidity
A Current Ratio of 1.08 indicates that COLL should not have too much problems paying its short term obligations.
COLL has a worse Current ratio (1.08) than 80.30% of its industry peers.
A Quick Ratio of 1.01 indicates that COLL should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.01, COLL is not doing good in the industry: 75.25% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 106.69% over the past year.
COLL shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 154.78% yearly.
The Revenue has grown by 17.18% in the past year. This is quite good.
COLL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 16.31% yearly.
EPS 1Y (TTM)106.69%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%2.76%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%22.66%
3.2 Future
COLL is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.42% yearly.
Based on estimates for the next years, COLL will show a small growth in Revenue. The Revenue will grow by 1.92% on average per year.
EPS Next Y8.96%
EPS Next 2Y5.37%
EPS Next 3Y-0.82%
EPS Next 5Y-5.42%
Revenue Next Year18.06%
Revenue Next 2Y10.67%
Revenue Next 3Y4.85%
Revenue Next 5Y1.92%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 4.44, which indicates a rather cheap valuation of COLL.
Compared to the rest of the industry, the Price/Earnings ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 96.97% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 25.91, COLL is valued rather cheaply.
The Price/Forward Earnings ratio is 4.02, which indicates a rather cheap valuation of COLL.
COLL's Price/Forward Earnings ratio is rather cheap when compared to the industry. COLL is cheaper than 96.46% of the companies in the same industry.
COLL's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 21.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.44 | ||
| Fwd PE | 4.02 |
4.2 Price Multiples
95.96% of the companies in the same industry are more expensive than COLL, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of COLL indicates a rather cheap valuation: COLL is cheaper than 97.47% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.71 | ||
| EV/EBITDA | 4.41 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of COLL may justify a higher PE ratio.
PEG (NY)0.5
PEG (5Y)N/A
EPS Next 2Y5.37%
EPS Next 3Y-0.82%
5. Dividend
5.1 Amount
No dividends for COLL!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
28.82
-0.65 (-2.21%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners117.57%
Inst Owner Change-1.12%
Ins Owners1.67%
Ins Owner Change2.53%
Market Cap925.99M
Analysts81.82
Price Target43.66 (51.49%)
Short Float %14.41%
Short Ratio11.06
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.4%
Min EPS beat(2)1.96%
Max EPS beat(2)12.85%
EPS beat(4)3
Avg EPS beat(4)5.22%
Min EPS beat(4)-0.88%
Max EPS beat(4)12.85%
EPS beat(8)7
Avg EPS beat(8)13.83%
EPS beat(12)8
Avg EPS beat(12)-13.44%
EPS beat(16)8
Avg EPS beat(16)-30.16%
Revenue beat(2)1
Avg Revenue beat(2)0.28%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)1.34%
Revenue beat(4)2
Avg Revenue beat(4)-0.03%
Min Revenue beat(4)-1.05%
Max Revenue beat(4)1.34%
Revenue beat(8)2
Avg Revenue beat(8)-1.39%
Revenue beat(12)5
Avg Revenue beat(12)-0.62%
Revenue beat(16)6
Avg Revenue beat(16)-5.22%
PT rev (1m)0%
PT rev (3m)-0.47%
EPS NQ rev (1m)1.34%
EPS NQ rev (3m)3.43%
EPS NY rev (1m)-0.25%
EPS NY rev (3m)5.51%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)0.61%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)0.33%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4.44 | ||
| Fwd PE | 4.02 | ||
| P/S | 1.39 | ||
| P/FCF | 4.71 | ||
| P/OCF | 4.67 | ||
| P/B | 3.95 | ||
| P/tB | N/A | ||
| EV/EBITDA | 4.41 |
EPS(TTM)6.49
EY22.52%
EPS(NY)7.16
Fwd EY24.85%
FCF(TTM)6.12
FCFY21.23%
OCF(TTM)6.18
OCFY21.43%
SpS20.67
BVpS7.3
TBVpS-23.41
PEG (NY)0.5
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 2.69% | ||
| ROE | 18.72% | ||
| ROCE | 12.41% | ||
| ROIC | 8.3% | ||
| ROICexc | 10.04% | ||
| ROICexgc | N/A | ||
| OM | 21.39% | ||
| PM (TTM) | 6.61% | ||
| GM | 57.69% | ||
| FCFM | 29.59% |
ROA(3y)2.08%
ROA(5y)4.15%
ROE(3y)14.01%
ROE(5y)18.34%
ROIC(3y)11.08%
ROIC(5y)9.32%
ROICexc(3y)16.99%
ROICexc(5y)14.94%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)16.56%
ROCE(5y)13.94%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y15.58%
ROICexc growth 5YN/A
OM growth 3Y43.71%
OM growth 5YN/A
PM growth 3Y-24.85%
PM growth 5YN/A
GM growth 3Y3.19%
GM growth 5Y11.47%
F-Score4
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 3.3 | ||
| Debt/FCF | 4.26 | ||
| Debt/EBITDA | 2.33 | ||
| Cap/Depr | 0.99% | ||
| Cap/Sales | 0.28% | ||
| Interest Coverage | 2.13 | ||
| Cash Conversion | 59.7% | ||
| Profit Quality | 447.8% | ||
| Current Ratio | 1.08 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 0.98 |
F-Score4
WACC9.58%
ROIC/WACC0.87
Cap/Depr(3y)142.93%
Cap/Depr(5y)207.67%
Cap/Sales(3y)41.34%
Cap/Sales(5y)49.06%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)106.69%
EPS 3Y154.78%
EPS 5YN/A
EPS Q2Q%2.76%
EPS Next Y8.96%
EPS Next 2Y5.37%
EPS Next 3Y-0.82%
EPS Next 5Y-5.42%
Revenue 1Y (TTM)17.18%
Revenue growth 3Y31.63%
Revenue growth 5Y16.31%
Sales Q2Q%22.66%
Revenue Next Year18.06%
Revenue Next 2Y10.67%
Revenue Next 3Y4.85%
Revenue Next 5Y1.92%
EBIT growth 1Y-25.89%
EBIT growth 3Y89.16%
EBIT growth 5YN/A
EBIT Next Year149.77%
EBIT Next 3Y32.76%
EBIT Next 5Y15.46%
FCF growth 1Y12%
FCF growth 3Y25.98%
FCF growth 5Y56.88%
OCF growth 1Y11.99%
OCF growth 3Y25.54%
OCF growth 5Y49.12%